- Testing is more important than ever, medical experts claim, urging government to speed up widespread testing
- Tens of millions of rapid, at-home tests may be needed every day
- UME offers rapid testing kits to help end the pandemic, ready to seize the opportunity
The U.S. government has announced plans to roll out more than 60 million home test kits to stop the COVID-19 virus from spreading (https://ibn.fm/O89KJ). United Medical Equipment Business Solutions Network (“UME”), a company offering a comprehensive line of COVID-19 products including rapid testing kits, stands ready to capitalize on the growing push for widespread testing and help slow the global pandemic.
Health experts agree with the new administration’s commitment to widespread rapid testing, but some fear that officials do not respond quickly enough. “Testing is actually more important now than it was eight months ago because of the high contagiousness rate of these new variants,” says Mara Aspinall, a professor of health practice at Arizona State University, said in a recent interview for NPR. “It is critical to stop these new strains right in their tracks. And the only way to do that is to test.”
Identifying infected people through country-wide rapid testing could be vital for curbing the virus and preventing new variants from emerging. The country reportedly needs tens of millions of tests every day to avoid another surge, while it buys time to get enough people vaccinated. “The virus still has an impressive grip on us. We need to be scaling these [tests] up today.”, said Dr. Michael Mina, an infectious disease epidemiologist at the Harvard T.H. Chan School of Public Health, in the article. Dr. Mina urges the Food and Drug Administration to approve more simple, rapid, inexpensive tests. They can be made quickly, thus enabling frequent testing of people at their homes.
Widespread rapid testing could jumpstart testing rates that have been stagnating at 1.6 million a day. At-home tests could make up for shortages in supplies, and the often-long wait times that come with the gold-standard PCR testing.
Other countries have already implemented rapid at-home testing. For example, amid the surge in COVID-19 cases in early 2021, the UK government announced it would roll out millions of cheap, rapid virus tests — a potential game changer in the fight against the virus (https://ibn.fm/ngMgh).
As a company committed to providing essential services during the epidemic, UME offers a comprehensive COVID-19 monitoring toolset designed with the assistance of medical experts. It includes data-driven COVID-19 testing of people with or without symptoms and could be useful for testing those in close contact with someone who has the virus. The Company appears ideally positioned to benefit from the pent-up demand for the rapid test as the push for widespread testing continues to grow.
For more information, visit the company’s website at www.UnitedMedSolutions.com.
NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.